Roberts HR - Search Results

1

Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.

Hoots WK, Ebbesen LS, Konkle BA, Auerswald GK, Roberts HR, Weatherall J, Ferran JM, Ljung RC; Novoseven (F7HAEM-1505) Investigators. Hoots WK, et al. Among authors: roberts hr. Haemophilia. 2008 May;14(3):466-75. doi: 10.1111/j.1365-2516.2008.01654.x. Epub 2008 Feb 12. Haemophilia. 2008. PMID: 18282155

2

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.

Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, Laurian Y, Kasper CK, Mannucci PM. Lusher JM, et al. Among authors: roberts hr. Haemophilia. 1998 Nov;4(6):790-8. doi: 10.1046/j.1365-2516.1998.00209.x. Haemophilia. 1998. PMID: 10028299 Clinical Trial.

3

Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.

Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U. Cooper HA, et al. Among authors: roberts hr. Haemophilia. 2001 Sep;7(5):517-22. doi: 10.1046/j.1365-2516.2001.00553.x. Haemophilia. 2001. PMID: 11554944

4

Progressive improvement in wound healing with increased therapy in haemophilia B mice.

Monroe DM, Hoffman M, Roberts HR, Hedner U. Monroe DM, et al. Among authors: roberts hr. Haemophilia. 2013 Nov;19(6):926-32. doi: 10.1111/hae.12220. Epub 2013 Jul 23. Haemophilia. 2013. PMID: 23879625

5

Clinical experience with activated factor VII: focus on safety aspects.

Roberts HR. Roberts HR. Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S115-8. Blood Coagul Fibrinolysis. 1998. PMID: 9819041

6

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study.

Macik BG, Lindley CM, Lusher J, Sawyer WT, Bloom AL, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR. Macik BG, et al. Among authors: roberts hr. Blood Coagul Fibrinolysis. 1993 Aug;4(4):521-7. doi: 10.1097/00001721-199308000-00001. Blood Coagul Fibrinolysis. 1993. PMID: 8218848 Clinical Trial.

7

10th Novo Nordisk Symposium on Haemostasis Management--introduction.

Roberts HR. Roberts HR. Haemophilia. 2010 May;16 Suppl 3:1-2. doi: 10.1111/j.1365-2516.2010.02251.x. Haemophilia. 2010. PMID: 20586793 No abstract available.

8

The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation.

Allen GA, Monroe DM 3rd, Roberts HR, Hoffman M. Allen GA, et al. Among authors: roberts hr. Blood Coagul Fibrinolysis. 2000 Apr;11 Suppl 1:S3-7. doi: 10.1097/00001721-200004001-00002. Blood Coagul Fibrinolysis. 2000. PMID: 10850556

9

Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.

Hoffman M, Monroe DM 3rd, Roberts HR. Hoffman M, et al. Among authors: roberts hr. Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S61-5. Blood Coagul Fibrinolysis. 1998. PMID: 9819030 Review.

10

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.

Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR. Lindley CM, et al. Among authors: roberts hr. Clin Pharmacol Ther. 1994 Jun;55(6):638-48. doi: 10.1038/clpt.1994.80. Clin Pharmacol Ther. 1994. PMID: 8004880 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page